000 01388 a2200397 4500
005 20250513234132.0
264 0 _c20010628
008 200106s 0 0 eng d
022 _a0887-8994
024 7 _a10.1016/s0887-8994(00)00249-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChamberlain, M C
245 0 0 _aRecurrent intracranial ependymoma in children: salvage therapy with oral etoposide.
_h[electronic resource]
260 _bPediatric neurology
_cFeb 2001
300 _a117-21 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAdolescent
650 0 4 _aAntineoplastic Agents, Phytogenic
_xadministration & dosage
650 0 4 _aBrain Neoplasms
_xdrug therapy
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aDrug Administration Schedule
650 0 4 _aEpendymoma
_xdrug therapy
650 0 4 _aEtoposide
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aProspective Studies
650 0 4 _aSalvage Therapy
650 0 4 _aSurvival Analysis
650 0 4 _aTreatment Outcome
773 0 _tPediatric neurology
_gvol. 24
_gno. 2
_gp. 117-21
856 4 0 _uhttps://doi.org/10.1016/s0887-8994(00)00249-6
_zAvailable from publisher's website
999 _c11211325
_d11211325